Login / Signup

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.

Helen StrongmanSolomon ChristopherMaila MajakRachael WilliamsShahram BahmanyarMarie LinderEdith M HeintjesDimitri BennettPasi KorhonenFabian Hoti
Published in: BMJ open diabetes research & care (2018)
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP; EUPAS3626).
Keyphrases
  • cardiovascular events
  • adverse drug
  • risk factors
  • cardiovascular disease